PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate0.070.07-0.60.12
Low Estimate0.070.07-0.60.1
High Estimate0.070.07-0.60.13
Year Ago EPS0.140.150.71-0.6
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate50.6M48.1M179.93M132.18M
Low Estimate50.6M48.1M176.05M118.9M
High Estimate50.6M48.1M183.8M145.46M
Year Ago Sales62.75M68.04M320.06M179.93M
Sales Growth (year/est)-19.40%-29.30%-43.80%-26.50%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.0.130.030.090.06
EPS Actual0.140.150.01-0.76
Difference0.010.12-0.08-0.82
Surprise %7.70%400.00%-88.90%-1,366.70%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate0.070.07-0.60.12
7 Days Ago0.070.07-0.60.12
30 Days Ago0.070.07-0.60.12
60 Days Ago0.040.040.140.13
90 Days Ago0.040.040.140.15
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPDLIIndustrySectorS&P 500
Current Qtr.-50.00%N/AN/A0.48
Next Qtr.-53.30%N/AN/A0.40
Current Year-184.50%N/AN/A0.21
Next Year120.00%N/AN/A0.10
Next 5 Years (per annum)14.00%N/AN/A0.11
Past 5 Years (per annum)-34.56%N/AN/AN/A